Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02258373 · ClinicalTrials.gov registry record · NA
A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes
A NA study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT02258373 is a NA study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 226 participants.
The verdict
NCT02258373, a NA study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The primary objective of the study is to determine whether the routine use of Continuous Glucose Monitoring (CGM) without Blood Glucose Monitoring (BGM) confirmation is as safe and effective as CGM used as an adjunct to BGM.
Interventions
- DEVICE CGM+BGM
- DEVICE CGM Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02258373
The ClinicalTrials.gov registry entry for NCT02258373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CGM+BGM is the first listed.
NCT02258373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02258373 about?
NCT02258373 is a clinical study titled "A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes". The primary objective of the study is to determine whether the routine use of Continuous Glucose Monitoring (CGM) without Blood Glucose Monitoring (BGM) confirmation is as safe and effective as CGM used as an adjunct to BGM.
What is the current status of trial NCT02258373?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2015-03. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02258373?
The interventions under investigation include: CGM+BGM (DEVICE), CGM Only (DEVICE).
Who is sponsoring clinical trial NCT02258373?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.